Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

At two Senate confirmation hearings, Kennedy played down his well-publicised questioning of the safety of childhood vaccines ...

GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine ...

A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...

Following similar deals in countries like the United States and the U.K., Canada is bolstering its stockpile of bird flu ...

The CDC's Advisory Committee on Immunization Practices was set to meet beginning February 26 and provide recommendations ...

The Advisory Committee on Immunization Practices (ACIP) meeting will be postponed to allow public comment prior to the ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...